Fake COVID testing racket busted in Bhubaneswar, one arrested
The police arrested a laboratory technician, Ganesh Kumar Pradhan (38) of Kunjabana in Nayagarh district who works at a private hospital here and stays at CDA.
Share Via Email
| A+A A- By Express News Service
CUTTACK: A day after 17,000 tablets of counterfeit Favipiravir, a drug recommended for treatment of Covid-19 were seized from a wholesaler in the city, an alleged fake testing racket was busted by Markat Nagar police here on Saturday.
The police arrested a laboratory technician, Ganesh Kumar Pradhan (38) of Kunjabana in Nayagarh district who works at a private hospital here and stays at CDA.
Shares of Aarti Drugs were up 6 per cent at Rs 708 on the BSE in intra-day trade on Tuesday after the pharmaceutical company said its board will consider share buyback on Friday, March 19. “A meeting of the board of directors of the company is scheduled to be held on Friday, March 19, 2021, to consider inter alia, proposal of buyback of the fully paid-up equity shares of the Company including matters related/incidental thereto,” Aarti Drug said in an exchange filing. The buyback is a corporate action in which a company buys back its shares from the existing shareholders usually at a price higher than the market price. When it buys back, the number of shares outstanding in the market reduces.
Updated Feb 12, 2021 | 19:20 IST
PNB Vesper, a leading Kerala based Life Sciences Company, today announced that it has successfully completed the phase 2 clinical trials of its proprietary drug PNB-001 (GPP-Baladol) on COVID-19 patients. Representational Image 
Key Highlights
Clinical trial report to be submitted to Drug Controller General of India on 22nd February 2021
PNB Vesper is a research-based bio-pharmaceutical organization that is determined to discover drugs for serious diseases
The drug molecule developed by the PNB Vesper team for the treatment of COVID-19 has already been patented and the related Intellectual Property Rights (IPRs) have been secured by PNB Vesper in the US, Europe and rest of the world